Document ID: chunk:federal_register_of_legislation:F2025L00062:schedule:1:p20
Version: federal_register_of_legislation:F2025L00062
Segment Type: schedule
Provision Reference: sch 1 (pt 20/51)
Character Range: 57949–60866

C5046     10  0     5     D(100)

[102] Schedule 1, Part 1, entry for Gentamicin
omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW
[103] Schedule 1, Part 1, entries for Hydroxocobalamin
substitute:
Hydroxocobalamin  Injection 1 mg (as acetate) in 1 mL   Injection  Cobal-B12    JU  MP NP MW  C16269 C16288 C16289     3  0     3
Hydroxocobalamin  Injection 1 mg (as acetate) in 1 mL   Injection  Vita-B12     GH  MP NP MW  C16269 C16288 C16289     3  0     3
Hydroxocobalamin  Injection 1 mg (as chloride) in 1 mL  Injection  Hydroxo-B12  AS  MP NP MW  C16269 C16288 C16289     3  0     3
Hydroxocobalamin  Injection 1 mg (as chloride) in 1 mL  Injection  Neo-B12      PF  MP NP MW  C16269 C16288 C16289     3  0     3

[104] Schedule 1, Part 1, entry for Indometacin in the form Suppository 100 mg [Maximum Quantity: 40; Number of Repeats: 3]
omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW
[105] Schedule 1, Part 1, entry for Iron polymaltose complex [Maximum Quantity: 5; Number of Repeats: 0]
omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW
[106] Schedule 1, Part 1, entry for Labetalol [Maximum Quantity: 100; Number of Repeats: 5]
(a) omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW
(b) insert in the column headed "Circumstances": C16261
(c) insert in the column headed "Purposes": P16261
[107] Schedule 1, Part 1, entry for Labetalol [Maximum Quantity: 200; Number of Repeats: 5]
insert in the column headed "Circumstances": C14238
[108] Schedule 1, Part 1, entry for Levonorgestrel in the form Intrauterine drug delivery system 19.5 mg
omit from the column headed "Authorised Prescriber": MP NP substitute: MP NP MW
[109] Schedule 1, Part 1, entry for Levonorgestrel in the form Intrauterine drug delivery system 52 mg
substitute:
Levonorgestrel  Intrauterine drug delivery system 52 mg  Intrauterine  Mirena  BN  MP NP MW  C5214           1  0     1
Levonorgestrel  Intrauterine drug delivery system 52 mg  Intrauterine  Mirena  BN  MP NP     C5135 C5289     1  0     1

[110] Schedule 1, Part 1, entry for Levothyroxine in the form Tablet containing 50 micrograms anhydrous levothyroxine sodium
(a) omit from the column headed "Authorised Prescriber" (all instances): MP NP substitute (all instances): MP NP MW
(b) insert in the column headed "Circumstances" (all instances): C16261
[111] Schedule 1, Part 1, entries for Levothyroxine in the form Tablet containing 75 micrograms anhydrous levothyroxine sodium
(a) omit from the column headed "Authorised Prescriber" (all instances): MP NP substitute (all instances): MP NP MW
(b) insert in the column headed "Circumstances" (all instances): C16261
[112] Schedule 1, Part 1, entries for Levothyroxine in the form Tablet containing 100 micrograms anhydrous levothyroxine sodium
(a) omit from the column headed "Authorised Prescriber"